2025 AGENDA

7:30 - 8:25 AM

Check-in & Networking Breakfast

8:25 - 8:35 AM

Opening & Hot Topics in the Retina Space

Presented By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

8:35 - 9:35 AM

Innovation Showcase

9:35 - 10:00 AM

Fireside Chat

Participants:
Rich Small, Chief Executive Officer - Neurotech

Moderated By:
John S. Pollack, MD, Partner - Illinois Retina Associates/ Chief Medical Officer - JCyte

10:00 - 10:30 AM

Investor perspectives on Success and Failure in Devices vs. Therapeutics

Moderated By:
James Murray, Partner - ExSight Ventures

10:30 - 11:00 AM

Morning Networking & Refreshment Break

11:00 - 11:55 AM

Spotlight on Oral or Topical Therapeutics for Retinal Diseases

Expert Panel Discussion

Panelists:
Michael Singer, MD - UT Health San Antonio

Moderated By:
Baruch Kuppermann, MD, PhD

11:55 - 12:40 PM

Drug Delivery Showcase

Overview Presented By:
Robert Bhisitkul, MD, PhD

12:40 - 1:25 PM

Networking Lunch

1:25 - 2:35 PM

Spotlight on Regenerative Therapies

Panelists:
Carlos Quezada-Ruiz, MD, FASRS, Assistant Professor of Ophthalmology, Retina and Vitreous, Instituto de Oftalmologia Fundación
John S. Pollack, MD, Partner - Illinois Retina Associates / Chief Medical Officer - jCyte

Moderated By:
Mark Humayun, MD, PhD

2:35 - 3:05 PM

Accelerating and Diversifying Clinical Trials in Ophthalmology: The Role of AI-Powered Innovation

Panelists:
Charlie Wykoff, MD, PhD

Moderated by:
Daniela Ferrara, MD, PhD, CMO - Topcon

3:05 - 3:30 PM

Afternoon Networking & Refreshment Break

3:30 - 4:30 PM

Spotlight on Dry AMD & GA

4:30 - 5:30 PM

The OIS Situation Room: Navigating healthcare in a shifting world order

Part 1 – Strategic Perspectives

Panelists:
Paul Hallen, Vice President of Global Retina at Alcon - Alcon
Nida Sen, MD, VP, Ophthalmology Strategy & Development Head – Sanofi
Julian Smith, General Manager Portfolio Commercial Strategy - Eye Care - AbbVie
Anthony Wallace, Vice President & General Manager - B+L

Part 2 – Finance Perspectives

Co-Moderated By:
Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer - REGENXBIO
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

5:30 - 6:30 PM

Networking Reception